MD, PhD Huber Veronica

Ricercatore

Contatti

Mail: veronica.huber@istitutotumori.mi.it
Tel: 0223903042

Veronica Huber è responsabile del laboratorio di Immunomonitoring e Immune Escape presso l’Unità di Immunologia Traslazionale.

Dopo la laurea in Medicina in Germania, ha intrapreso la carriera scientifica in INT conseguendo il Dottorato di Ricerca e maturando oltre 20 anni di esperienza nel campo dell’immunologia tumorale, con un focus particolare sulle cellule mieloidi soppressorie (MDSC) e sulle vescicole extracellulari.

La sua attività di ricerca si concentra sull’identificazione dei meccanismi immunologici di risposta e resistenza alle terapie, nonché di biomarcatori immunologici rilevabili nella biopsia liquida di pazienti oncologici sottoposti a immunoterapia e ad altri trattamenti antitumorali, in diversi contesti clinici.

Elenco pubblicazioni Orcid

(2025-2030) Collaborating Researcher in AIRG IG-30422 “Actioning the resistance mechanisms to different antibody-drug conjugates in gastric cancer”

(2025-2027) Partner in NANOTECMEC- JTC 2024: “Synthetic Ago/antagoMIR nanovehicles for Immunoregulation: a possible approach in cancer and Lung transplantation (the “SAIL” project)

(2025-2026) Co-PI of INT grant: “Delta-tocotrienol-mediated constraIn oF systemic inFlammation induces intra-tumor immunity in Early bREast caNCer patiEnts (the DIFFERENCE project)”

(2024-2025) PI of National Facilities – Human Technopole grant: “Plasma Extracellular Vesicle RNA as predictive biomarker of immunotherapy outcome in a pan-cancer setting”

(2024-2025) Co-PI of INT grant: “Understanding tumor and immune dynamics and predicting poor outcome to intravesical therapies (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC) that had progressed in locally advanced/metastatic disease”

(2020-2024) PI of 5-year AIRC IG-25078 grant “Genetic and epigenetic regulation of local and systemic myeloid cells in response to immunotherapy of cancer patients”

(2019-2021) PI of grant Fondi 5x1000 Ministero della Salute 2015 “Circulating extracellular vesicles as biomarker of therapeutic immune modulation in cancer patients”

(2006–2008) PI of AIRC IG-4420 grant “Role of granulocytes in maintenance of chronic inflammation and immune suppression in cancer patients"